title: Diagnostic testing in extraesophageal GERD: another case of "furor medicus"?
abstract: Proton pump inhibitors (PPIs) work for most patients with gastroesophageal reflux disease (GERD). But when PPIs fail to work, or when there are atypical extra-esophageal symptoms, diagnostic and management decisions become much more difficult. Although atypical GERD is common, there are limited data about how best to approach these patients. The temptation is often to perform extensive diagnostic testing, sometimes to little avail. In this issue of The Journal, Francis et al. present a new study to help close the research gap in understanding the costs and benefits of testing in atypical GERD. The authors conclude that diagnostic testing is very expensive and real-life benefits are modest. This editorial reviews the findings, places them into clinical perspective, and concludes that diagnostic testing in atypical GERD may be another example of "furor medicus" - an old but descriptive term referring to the instinct of doctors to implore "don't just stand there, do something!" The data from Francis et al. suggest we might do the opposite in atypical GERD: "Don't just do something, stand there."
authors.forename: Brennan
authors.initials: B
authors.lastname: Spiegel
mesh_terms: D017281:Cost of Illness; D005260:Female; D005764:Gastroesophageal Reflux / Q000150:complications* / Q000191:economics*; D017048:Health Care Costs; D006801:Humans; D008297:Male